ipilimumab,nivolumab
bms
['ipi/', 'nivolumab', 'nivo']
dr schenk presents response guided trial with concomitant tacrolimus and nivolumab for kidney transplanted patients with cutaneous malignancies. nivo alone no effect (8/8 pd) and 1/8 graft loss. ipi/nivo more effective (2/8 cr) but with 2/8 graft losses. #asco22 
Associate professor in Surgery at Sahlgrenska University Hospital. @sahlgrenska @SahlgrenskaAcad @goteborgUni #wcmtm #melanoma #breastcancer #surgery